John Kelly, MD
Neurology · Wasilla, AKNPI 1407855315
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $8,588 of the $12,929 with a category attached, or 66.4%. TG Therapeutics, Inc. accounts for 72.9% of it on its own, with 36 other manufacturers making up the rest. 2025 is the largest year on record at $9,946, more than ten times the $138 reported in 2019.
Across 175 payments — averaging $73.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- TG Therapeutics, Inc.$9K
- AbbVie$477
- AstraZeneca$271
- UCB, Inc.$205
- EMD Serono, Inc.$203
- Sanofi$196
- plus $2K from 31 others
What the payments were for
- Speaking & faculty fees$8,58866%
- Food & beverage$4,22533%
- Education$1161%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| TG Therapeutics, Inc. | 25 | $9,431 |
| AbbVie(2 entities) | 22 | $477 |
| AstraZeneca(2 entities) | 9 | $271 |
| UCB, Inc. | 9 | $205 |
| EMD Serono, Inc. | 3 | $203 |
| Sanofi | 7 | $196 |
| Biogen | 7 | $192 |
| Pfizer | 6 | $188 |
| SK Life Science, Inc. | 5 | $178 |
| Neurocrine Biosciences, Inc. | 7 | $131 |
| Genentech USA, Inc. | 3 | $131 |
| Boehringer Ingelheim | 6 | $108 |
| Lundbeck LLC | 6 | $105 |
| Eisai Inc. | 4 | $88 |
| Acadia Pharmaceuticals Inc | 6 | $88 |
| Johnson & Johnson | 5 | $86 |
| Boston Scientific | 2 | $83 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $74 |
| Biohaven Pharmaceuticals, Inc. | 4 | $72 |
| Teva Pharmaceuticals USA, Inc. | 5 | $71 |
| Argenx US, Inc. | 3 | $56 |
| Lilly USA, LLC | 3 | $54 |
| Gilead | 4 | $51 |
| Amgen | 2 | $43 |
| Impel Pharmaceuticals Inc. | 2 | $41 |
| Neurelis, Inc. | 2 | $41 |
| Jazz Pharmaceuticals Inc. | 2 | $41 |
| Novartis | 2 | $38 |
| Daiichi Sankyo Inc. | 2 | $37 |
| Averitas Pharma Inc. | 1 | $29 |
| TMS Neurohealth Centers Inc. | 1 | $25 |
| Livanova USA, Inc. | 1 | $20 |
| Aprecia Pharmaceuticals, LLC | 1 | $17 |
| Mallinckrodt Hospital Products Inc. | 1 | $17 |
| Avion Pharmaceuticals | 1 | $15 |
| Amneal Pharmaceuticals LLC | 1 | $14 |
| Intercept Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,929 in reported general payments places this provider in the 85th percentile of 21 neurology providers in Alaska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lamotrigine ErLamotrigine | 16 | $1,881 |
| Memantine Hcl | 30 | $1,336 |
| Entacapone | 11 | $848 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 24 | $772 |
| Levetiracetam | 22 | $691 |
| Primidone | 42 | $649 |
| Donepezil Hcl | 53 | $643 |
| Lamotrigine | 25 | $320 |
| Baclofen | 13 | $239 |
| ClopidogrelClopidogrel Bisulfate | 14 | $190 |
| Gabapentin | 14 | $138 |
| Topiramate | 11 | $93 |
Paid to pharmacies, not to this prescriber.
Other neurology in Wasilla
- Jeffrey SponslerWasilla$8K
- Kristen JessenSoldotna$51K
- Stanford DownsAnchorage$19K
- Mary DownsAnchorage$17K
- Peter OsterbauerEagle River$12K
- Scot HinesAnchorage$8K
- David HenzlerAnchorage$6K
- Naomi ArensonSoldotna$4K
- Ronald MartinoFairbanks$4K
- Aaron TauerAnchorage$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.